Completed NA INTERVENTIONAL 2-arm NCT02345135

Susceptibility to Infections in Ataxia Telangiectasia

Susceptibility to Infections in Patients With Ataxia Telangiectasia : A Prospective Follow-up Study

Sponsor: CSL Behring

Conditions Ataxia Telangiectasia Immunodeficiency Infections Lung Disease

Interventions Blood collection Lung function measurement Symptom diary

Updated 7 times since 2017 Last updated: Nov 29, 2017 Started: Sep 30, 2012 Primary completion: Jan 31, 2016 Completion: Jul 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02345135, this NA trial focuses on Ataxia Telangiectasia and Immunodeficiency and remains completed. Sponsored by CSL Behring, it has been updated 7 times since 2012, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Dec 2017 — Jun 2018 [monthly]

Completed NA

Status: Unknown Status → Completed

▶ Show 2 earlier versions

Feb 2017 — Dec 2017 [monthly]

Unknown Status NA

Status: Enrolling By Invitation → Unknown Status
Jan 2017 — Feb 2017 [monthly]

Enrolling By Invitation NA

First recorded

Sep 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CSL Behring
Johann Wolfgang Goethe University Hospital

Data source: Johann Wolfgang Goethe University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.